<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>TNF-alpha is a pleitropic cytokine that expresses both pro- and anti-inflammatory activity and transgenic mice expressing human <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha (TNF-alpha) exhibit a progressive <z:e sem="disease" ids="C0162323" disease_type="Disease or Syndrome" abbrv="">polyarthritis</z:e> that models <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> (RA) </plain></SENT>
<SENT sid="1" pm="."><plain>One of the common comorbidities of RA is <z:hpo ids='HP_0001903'>anemia</z:hpo> of <z:hpo ids='HP_0011010'>chronic</z:hpo> disease (ACD) </plain></SENT>
<SENT sid="2" pm="."><plain>The purpose of these experiments was to study the changes in the bone marrow and peripheral blood that accompany <z:e sem="disease" ids="C0162323" disease_type="Disease or Syndrome" abbrv="">polyarthritis</z:e> in TNF-alpha transgenic mice in an effort to better understand the pathogenesis of <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> and ACD </plain></SENT>
<SENT sid="3" pm="."><plain>Polychromatic cytometry, hematology and serum cytokine analysis were used to study the pathogenesis of ACD in human TNF-alpha transgenic mice </plain></SENT>
<SENT sid="4" pm="."><plain>Our hematological evaluation revealed a mild, compensated, microcytic <z:hpo ids='HP_0001931'>hypochromic anemia</z:hpo>, and <z:mp ids='MP_0000220'>monocytosis</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>In the bone marrow, we observed alterations in cell kinetics, decreased relative expression of transferrin receptor and <z:mp ids='MP_0006042'>increased apoptosis</z:mp> and cell <z:hpo ids='HP_0011420'>death</z:hpo> in several late precursor cell populations </plain></SENT>
<SENT sid="6" pm="."><plain>Although significant levels of human TNF-alpha were found in the serum, neither change in serum murine erythropoietin nor any significant difference observed in serum levels of murine IL-beta, IL-5, IL-6, IL-10, IL-12(p70), IL-17, TNF-alpha, IFNgamma, GM-CSF, MIP-1alphaJE, <z:chebi fb="17" ids="50099">MCP</z:chebi>-5 was observed </plain></SENT>
<SENT sid="7" pm="."><plain>Tg197 mice develop a compensated, microcytic, <z:hpo ids='HP_0001931'>hypochromic anemia</z:hpo>, and a functional <z:e sem="disease" ids="C0240066" disease_type="Disease or Syndrome" abbrv="">iron deficiency</z:e> by 9 weeks of age </plain></SENT>
<SENT sid="8" pm="."><plain>Changes in peripheral blood are reflected in alterations in cell kinetics, transferrin receptor expression and markedly <z:mp ids='MP_0006042'>increased apoptosis</z:mp> and cell <z:hpo ids='HP_0011420'>death</z:hpo> in the bone marrow indicating that TNF-alpha may contribute to <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> in ACD </plain></SENT>
<SENT sid="9" pm="."><plain>Moreover, since human TNF-alpha can interact only with murine TNFR1, our data suggest that TNFR1 may play an important role in the development of ACD </plain></SENT>
</text></document>